LABORATORY NEWS
-
BD Launches Combination Test For COVID-19, Influenza A/B And Respiratory Syncytial Virus
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the BD MAX™ Respiratory Viral Panel (RVP), a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV), has been CE marked to the IVD directive 98/79/EC.
- Elevation Diagnostics Moves To Fitzsimons Innovation Community Campus In Aurora, Colorado
- Anitoa Launches Molecular Test (PCR) For Monkeypox
- Labcorp Plans Laboratory Expansion In Japan Through BML Collaboration
- Community Health Network And Grail Partner To Offer Galleri Multi-Cancer Early Detection Test In Central Indiana
ARCHIVED NEWSLETTER
- 06.28.22 -- wNMR: Spectroscopy From Biomanufacturing To Point-Of-Care
- 06.14.22 -- New ICH Q14 Guidance Applies QbD To Analytical Procedures
- 06.08.22 -- New Episodes for You: Live Biologics & The Microbiome, Inside CAR-T Therapy for Ovarian Cancer and more.
- 05.24.22 -- FDA Seeks Public Comment On Quality Metrics Reporting Program
- 05.10.22 -- The Clinical Trial Sponsor's Roadmap To Avoid EMA (Cyber) Perdition
This website uses cookies to ensure you get the best experience on our website. Learn more